4-Epiabietic acid

Details

Top
Internal ID 53789b40-2f50-449b-b534-f4796d048e90
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Diterpenoids
IUPAC Name (1S,4aR,4bR,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid
SMILES (Canonical) CC(C)C1=CC2=CCC3C(C2CC1)(CCCC3(C)C(=O)O)C
SMILES (Isomeric) CC(C)C1=CC2=CC[C@@H]3[C@@]([C@H]2CC1)(CCC[C@]3(C)C(=O)O)C
InChI InChI=1S/C20H30O2/c1-13(2)14-6-8-16-15(12-14)7-9-17-19(16,3)10-5-11-20(17,4)18(21)22/h7,12-13,16-17H,5-6,8-11H2,1-4H3,(H,21,22)/t16-,17+,19+,20-/m0/s1
InChI Key RSWGJHLUYNHPMX-CUDHKJQZSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C20H30O2
Molecular Weight 302.50 g/mol
Exact Mass 302.224580195 g/mol
Topological Polar Surface Area (TPSA) 37.30 Ų
XlogP 4.80
Atomic LogP (AlogP) 5.21
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 2

Synonyms

Top
24563-90-4

2D Structure

Top
2D Structure of 4-Epiabietic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9971 99.71%
Caco-2 + 0.8501 85.01%
Blood Brain Barrier + 0.7000 70.00%
Human oral bioavailability + 0.6143 61.43%
Subcellular localzation Mitochondria 0.5180 51.80%
OATP2B1 inhibitior - 0.8634 86.34%
OATP1B1 inhibitior - 0.7737 77.37%
OATP1B3 inhibitior - 0.5698 56.98%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior + 0.5500 55.00%
BSEP inhibitior + 0.7884 78.84%
P-glycoprotein inhibitior - 0.8263 82.63%
P-glycoprotein substrate - 0.8345 83.45%
CYP3A4 substrate + 0.5889 58.89%
CYP2C9 substrate - 0.6168 61.68%
CYP2D6 substrate - 0.8908 89.08%
CYP3A4 inhibition - 0.9288 92.88%
CYP2C9 inhibition + 0.8611 86.11%
CYP2C19 inhibition + 0.8347 83.47%
CYP2D6 inhibition - 0.9231 92.31%
CYP1A2 inhibition - 0.8620 86.20%
CYP2C8 inhibition - 0.7966 79.66%
CYP inhibitory promiscuity - 0.8602 86.02%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8700 87.00%
Carcinogenicity (trinary) Non-required 0.6088 60.88%
Eye corrosion - 0.9780 97.80%
Eye irritation - 0.6445 64.45%
Skin irritation - 0.6792 67.92%
Skin corrosion - 0.9810 98.10%
Ames mutagenesis - 0.9754 97.54%
Human Ether-a-go-go-Related Gene inhibition - 0.4477 44.77%
Micronuclear - 0.9200 92.00%
Hepatotoxicity - 0.5551 55.51%
skin sensitisation + 0.7847 78.47%
Respiratory toxicity + 0.8333 83.33%
Reproductive toxicity + 0.6333 63.33%
Mitochondrial toxicity + 0.7375 73.75%
Nephrotoxicity - 0.7125 71.25%
Acute Oral Toxicity (c) III 0.6392 63.92%
Estrogen receptor binding - 0.5000 50.00%
Androgen receptor binding - 0.4911 49.11%
Thyroid receptor binding + 0.6946 69.46%
Glucocorticoid receptor binding + 0.7476 74.76%
Aromatase binding - 0.7430 74.30%
PPAR gamma + 0.8707 87.07%
Honey bee toxicity - 0.9235 92.35%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity - 0.6900 69.00%
Fish aquatic toxicity + 1.0000 100.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4040 P28482 MAP kinase ERK2 94.89% 83.82%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.01% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.29% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 92.10% 97.25%
CHEMBL2581 P07339 Cathepsin D 89.63% 98.95%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 89.40% 94.45%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 85.46% 95.56%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.75% 100.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 84.37% 97.09%
CHEMBL3359 P21462 Formyl peptide receptor 1 83.51% 93.56%
CHEMBL340 P08684 Cytochrome P450 3A4 83.16% 91.19%
CHEMBL221 P23219 Cyclooxygenase-1 81.65% 90.17%
CHEMBL4227 P25090 Lipoxin A4 receptor 80.80% 100.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 80.68% 95.89%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 80.59% 99.23%

Cross-Links

Top
PubChem 6973653
NPASS NPC285390
LOTUS LTS0014114
wikiData Q104253217